BIBDX
Price
$13.09
Change
+$0.07 (+0.54%)
Updated
Jun 2 closing price
Net Assets
895.99M
SGIFX
Price
$45.16
Change
+$0.65 (+1.46%)
Updated
Jun 2 closing price
Net Assets
496.57M
Interact to see
Advertisement

BIBDX vs SGIFX

Header iconBIBDX vs SGIFX Comparison
Open Charts BIBDX vs SGIFXBanner chart's image
BIBDX vs SGIFX Comparison Chart in %
View a ticker or compare two or three
VS
BIBDX vs. SGIFX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIBDX is a Hold and SGIFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BIBDX has more cash in the bank: 896M vs. SGIFX (497M). BIBDX pays higher dividends than SGIFX: BIBDX (1.29) vs SGIFX (0.73). BIBDX was incepted earlier than SGIFX: BIBDX (18 years) vs SGIFX (8 years). SGIFX (2.02) is less costly to investors than BIBDX (0.80). BIBDX is a more actively managed with annual turnover of: 44.00 vs. SGIFX (37.00). SGIFX has a lower initial minimum investment than BIBDX: SGIFX (1000) vs BIBDX (2000000). SGIFX annual gain was more profitable for investors over the last year : 21.19 vs. BIBDX (4.72). SGIFX return over 5 years is better than : 16.65 vs. BIBDX (-1.02).
BIBDXSGIFXBIBDX / SGIFX
Total Expense Ratio0.802.0240%
Annual Report Gross Expense Ratio0.802.0240%
Fund Existence18 years8 years-
Gain YTD10.43812.13186%
Front LoadN/AN/A-
Min. Initial Investment20000001000200,000%
Min. Initial Investment IRAN/AN/A-
Net Assets896M497M180%
Annual Yield % from dividends1.290.73177%
Returns for 1 year4.7221.1922%
Returns for 3 years23.6652.0046%
Returns for 5 years-1.0216.65-6%
Returns for 10 years32.00N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FINW14.440.36
+2.56%
FinWise Bancorp
MCBS33.160.73
+2.25%
MetroCity Bankshares
PTEN11.730.20
+1.78%
Patterson-UTI Energy
KDP30.360.16
+0.53%
Keurig Dr Pepper
LEXX0.60-0.01
-2.17%
Lexaria Bioscience Corp